Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-016538
Filing Date
2025-06-25
Accepted
2025-06-25 17:30:13
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3983
  Complete submission text file 0001641172-25-016538.txt   5434
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Melincoff Gwen A (Reporting) CIK: 0001614890 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40237 | Film No.: 251074589

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)